SG Americas Securities, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 117 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$320
+19.0%
58,720
+46.6%
0.00%
+100.0%
Q2 2023$269
-60.4%
40,062
-47.9%
0.00%
-75.0%
Q1 2023$679
+207.2%
76,854
+165.4%
0.01%
+166.7%
Q4 2022$221
-99.9%
28,962
+22.6%
0.00%
+50.0%
Q3 2022$168,000
-59.0%
23,623
-53.4%
0.00%
-50.0%
Q2 2022$410,000
+17.1%
50,678
+100.8%
0.00%
+33.3%
Q1 2022$350,000
-47.8%
25,239
+5.7%
0.00%
-25.0%
Q4 2021$670,000
+85.6%
23,876
+124.9%
0.00%
+100.0%
Q3 2021$361,000
+15.7%
10,614
+38.8%
0.00%
+100.0%
Q2 2021$312,000
-70.5%
7,645
-70.9%
0.00%
-83.3%
Q1 2021$1,059,000
+789.9%
26,301
+1203.3%
0.01%
+500.0%
Q4 2020$119,000
-77.7%
2,018
-81.6%
0.00%
-66.7%
Q3 2020$534,000
+173.8%
10,982
+68.4%
0.00%
+50.0%
Q4 2019$195,000
-73.1%
6,520
-56.5%
0.00%
-60.0%
Q2 2019$724,00015,0000.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2019
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders